Tag Archives: ILLUMENATE European Randomized Controlled Trial

Four-year results from EU RCT validate the long-term safety profile of Philips’ Stellarex low-dose Drug-Coated Balloon

(PRESS RELEASE) AMSTERDAM, 26-Jun-2020 — /EuropaWire/ — The global leader in health technology Royal Philips (NYSE: PHG, AEX: PHIA) has announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). New data from the EU RCT reconfirms … Read the full press release